Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Inflammatory Diseases of the Middle Ear Workup

  • Author: Diego A Preciado, MD, PhD, FAAP; Chief Editor: Arlen D Meyers, MD, MBA  more...
 
Updated: Feb 08, 2016
 

Laboratory Studies

Culturing of the discharge after a spontaneous perforation in patients with acute suppurative otitis media is reliable in only the first few hours because external ear canal flora contaminates the otorrhea.

Next

Imaging Studies

See the list below:

  • Cholesteatoma is usually treated surgically. Bearing this in mind, radiologic evaluation serves to demonstrate any underlying anatomical variation and to assist in diagnosing both the extent and the nature of pathological change. The extent of mastoid pneumatization influences the surgical approach taken.
    • CT scanning is generally the imaging modality of choice in the assessment of cholesteatoma.
      • High-resolution CT scans can demonstrate bony erosion of the tegmen, the lateral semicircular, and the bony covering of the facial nerve. Ossicular erosion of the malleus and the incus is often visible on CT scans, although stapes erosion is frequently not demonstrated.
      • MRIs are inferior to CT scans in demonstrating bony abnormalities associated with cholesteatoma. However, MRIs help distinguish between the different pathological processes that cause soft tissue accumulation in the mastoid and the middle ear spaces.
      • MRIs are particularly useful in distinguishing among cholesteatoma, cholesterol granuloma, and inflammatory granulation tissue.
    • Radiologic documentation of ears with chronic cholesteatoma, which usually require surgery, reveals underlying anatomical variations and assists in diagnosis of the extent and the nature of the disease.
    • Plain radiographs may depict the height of the middle fossa dura and the site of the sigmoid sinus, but they usually reveal little information on the extent of disease.
      • Both CT scans and MRIs can reveal the disease and its extent.
      • CT scans reveal a nonenhancing mass eroding the bone, including the ossicles, with sharply defined smooth margins, isodense with CSF; likewise, MRI depicts a mass with a low-intensity T1-weighted signal and a high T2 signal. In practice, distinguishing between cholesteatoma and pure mucosal disease is often difficult on imaging.
    • A high-definition CT scan of the petrous temporal bone depicts the extent of the mastoid disease, although it may not assist in distinguishing cholesteatoma from mucosal disease.
  • High-resolution CT scanning has allowed better detection of acute otomastoiditis. The mastoid air cells appear opacified because of mucosal swelling and the presence of mucus or mucopurulent secretions. With effective therapy, the inflammatory process can be arrested, and the mastoid air cells resume a normal radiographic appearance.
  • A gadolinium-enhanced magnetic resonance scan is currently the imaging modality of choice to aid in the diagnosis of intracranial venous thrombosis and intracranial abscess.
    • With intracranial venous thrombosis, simple thrombus shows an intermediate signal; vascularized thrombus, granulation tissue, and slow-flowing blood show a high signal; and fast-flowing blood shows no signal.
    • Intracranial abscess shows a center of low attenuation with an outer rim of a high signal.
Previous
Next

Other Tests

See the list below:

  • Audiometry is not diagnostic, but it allows an examiner to assess the severity of the patient's condition.
    • Audiometry may also be used to monitor the progress of the patient's condition.
    • According to observations made in a prospective cohort study of 3-year-old children, dry ears have a mean hearing threshold of 17 dB, while ears with mild chronic secretory otitis media (SOM) and moderate chronic SOM have thresholds of 23 dB and 29 dB, respectively.
Previous
Next

Histologic Findings

The degree of inflammation in chronic suppurative otitis media (CSOM) without cholesteatoma is related to clinical activity, with the most intense changes seen in ears with continuous otorrhea. First, chronic inflammatory infiltrate (eg, lymphocytes, plasma cells, histiocytes) develops with increased capillary permeability of the lamina propria of the middle ear mucosa and resultant mucosal edema. The middle ear epithelium transforms as counts of goblet cells and ciliated cells increase, with the epithelium generally becoming more glandular and secretory.

Inflammatory granulation tissue develops during the early stages of healing after the destruction of the tissue. Sometimes, polyps covered with ciliated columnar epithelium form when the granulation tissue is florid. Later, the disease is characterized by decreased vascularity, fibrosis with sclerosis, and new bone formation in the mastoid air cells.

Ossicular changes are mainly due to osteoclastic bone resorption in granulation tissue or avascular necrosis. New bone formation may occur with fixation of the heads of the malleus and the incus in the attic. A foreign body granulomatous response to cholesterol crystals can result after hemorrhage into the middle ear, with crystals surrounded by foreign body giant cells and other chronic inflammatory cells. Tympanosclerosis is associated with CSOM with hyalinization of collagen and calcium deposition and may result from a specific autoimmune reaction.

Cholesteatomatous CSOM appears macroscopically as a crystallike structure with pale debris in the middle ear cleft. Light microscopy reveals a matrix of fully differentiated stratified squamous epithelium resting on connective tissue. The central core of cholesteatoma consists of anucleate keratin squames. Other inflammatory changes are similar to noncholesteatomatous CSOM, including aural polyps. Histologically, aural polyps that consist of granulation tissue with keratin as masses or flakes suggest that cholesteatoma is a likely diagnosis. Conversely, polyps without this feature but with lymphoid aggregates, a connective tissue core with glands, and a covering epithelium make cholesteatoma a much less likely diagnosis. Epidermal Langerhans cells are found in high numbers in cholesteatoma and are thought to be epidermal macrophages.

Previous
 
 
Contributor Information and Disclosures
Author

Diego A Preciado, MD, PhD, FAAP Assistant Professor, Department of Otolaryngology, Division of Pediatric Otolaryngology, George Washington University School of Medicine, Children's National Medical Center

Diego A Preciado, MD, PhD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, Association for Research in Otolaryngology, American Society of Pediatric Otolaryngology, American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Gerard J Gianoli, MD Clinical Associate Professor, Departments of Otolaryngology-Head and Neck Surgery and Pediatrics, Tulane University School of Medicine; President, The Ear and Balance Institute; Board of Directors, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, Triological Society, American Neurotology Society, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Vesticon<br/>Received none from Vesticon, Inc. for board membership.

Chief Editor

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;SymbiaAllergySolutions<br/>Received income in an amount equal to or greater than $250 from: Symbia<br/>Received from Allergy Solutions, Inc for board membership; Received honoraria from RxRevu for chief medical editor; Received salary from Medvoy for founder and president; Received consulting fee from Corvectra for senior medical advisor; Received ownership interest from Cerescan for consulting; Received consulting fee from Essiahealth for advisor; Received consulting fee from Carespan for advisor; Received consulting fee from Covidien for consulting.

Additional Contributors

John C Li, MD Private Practice in Otology and Neurotology; Medical Director, Balance Center

John C Li, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Neurotology Society, American College of Surgeons, American Medical Association, American Tinnitus Association, Florida Medical Association, North American Skull Base Society

Disclosure: Received consulting fee from Synthes Power Tools for consulting.

Acknowledgements

The authors and editors of Medscape Drugs & Diseases gratefully acknowledge previous authors Nasir Aziz, MD, MA, Resident Physician, Riverside Regional Medical Center, and Sanjeev Silva, MBBS, MRCS, DLO, Senior House Officer, Department of Otorhinolaryngology, Head and Neck, Facial Plastics, Great Ormond Street Hospital for Sick Children, UK, for their contributions to this article.

References
  1. Cunningham M, Guardiani E, Kim HJ, Brook I. Otitis media. Future Microbiol. 2012 Jun. 7(6):733-53. [Medline].

  2. Stol K, Diavatopoulos DA, Graamans K, Engel JA, Melchers WJ, Savelkoul HF, et al. Inflammation in the Middle Ear of Children with Recurrent or Chronic Otitis Media is Associated with Bacterial Load. Pediatr Infect Dis J. 2012 Jun 4. [Medline].

  3. Marom T, Nokso-Koivisto J, Chonmaitree T. Viral-Bacterial Interactions in Acute Otitis Media. Curr Allergy Asthma Rep. 2012 Sep 12. [Medline].

  4. Iino Y, Nagamine H, Kakizaki K, et al. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol. 2006 Dec. 97(6):761-6. [Medline].

  5. Hurst DS. The role of allergy in otitis media with effusion. Otolaryngol Clin North Am. 2011 Jun. 44(3):637-54, viii-ix. [Medline].

  6. Coughlin L. AHRQ data on antibiotic use in children with otitis media. American Family Physician. June 2005.

  7. Vayisoglu Y, Gorur K, Ozcan C, Korlu S. Unusual complication of otitis media with effusion: facial nerve paralysis. J Craniofac Surg. 2011 Jul. 22(4):1525-7. [Medline].

  8. Browning GC. Medical management of chronic mucosal otitis media. Clin Otolaryngol Allied Sci. 1984 Jun. 9(3):141-4. [Medline].

  9. Dubey SP, Larawin V, Molumi CP. Intracranial spread of chronic middle ear suppuration. Am J Otolaryngol. 2009 Mar 31. [Medline].

  10. McCormick DP, Jennings K, Ede LC, Alvarez-Fernandez P, Patel J, Chonmaitree T. Use of symptoms and risk factors to predict acute otitis media in infants. Int J Pediatr Otorhinolaryngol. 2016 Feb. 81:55-9. [Medline].

  11. Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngol Head Neck Surg. 2016 Feb. 154 (1 Suppl):S1-S41. [Medline]. [Full Text].

  12. Frellick M. Otitis Media: New Guideline Includes Screening At-Risk Kids. Medscape Medical News. 2016 Feb 4. [Full Text].

  13. Barclay L. Postop Tympanostomy Tube Obstruction Common. Medscape Medical News. Jul 2014. [Full Text].

  14. Conrad DE, Levi JR, Theroux ZA, et al. Risk factors associated with postoperative tympanostomy tube obstruction. JAMA Otolaryngol Head Neck Surg. 2014 Aug 1. 140(8):727-30. [Medline].

  15. Balbani AP, Montovani JC. [Impact of otitis media on language acquisition in children]. J Pediatr (Rio J). 2003 Sep-Oct. 79(5):391-6. [Medline].

  16. Balbani AP, Montovani JC. [Impact of otitis media on language acquisition in children]. J Pediatr (Rio J). 2003 Sep-Oct. 79(5):391-6. [Medline].

  17. Casselbrant ML, Mandel EM, Rockette HE, Kurs-Lasky M, Fall PA, Bluestone CD, et al. The genetic component of middle ear disease in the first 5 years of life. Arch Otolaryngol Head Neck Surg. 2004 Mar. 130(3):273-8. [Medline].

  18. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev. 2003 Apr. 16(2):230-41. [Medline].

  19. Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy. 2005 Oct. 35(10):1370-6. [Medline].

  20. Katherine L. O’Brien and Mathuram Santosham Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases. Am J Epidemiol; 2004. 159: 634-644.

  21. Miceli Sopo S, Zorzi G, Calvani M Jr. Should we screen every child with otitis media with effusion for allergic rhinitis?. Arch Dis Child. 2004 Mar. 89(3):287-8. [Medline].

  22. Patel JA, Nguyen DT, Revai K, Chonmaitree T. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine. 2007 Feb 19. 25(9):1683-9. Epub 2006 Nov 9. [Medline].

  23. Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut. 2005 Oct. 54(10):1492-9. [Medline].

  24. Spector ND, Kelly SF. Medical home, obesity, acute otitis media, and otitis media with effusion. Curr Opin Pediatr. 2004 Dec. 16(6):706-22. [Medline].

 
Previous
Next
 
Middle ear anatomy.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.